(Q45306474)

11 December 2017

title

Homozygosity in Huntington's disease: new ethical dilemma caused by molecular diagnosis (English)

1 reference

11 December 2017

0 references

1 reference

1 reference

Alonso ME

1

1 reference

11 December 2017

Yescas P

2

1 reference

11 December 2017

Rasmussen A

3

1 reference

11 December 2017

Ochoa A

4

1 reference

11 December 2017

Macías R

5

1 reference

11 December 2017

Ruiz I

6

1 reference

11 December 2017

Suástegui R

7

1 reference

11 December 2017

publication date

1 June 2002

1 reference

11 December 2017

1 reference

11 December 2017

volume

61

1 reference

11 December 2017

issue

6

1 reference

11 December 2017

page(s)

437-442

1 reference

A polymorphic DNA marker genetically linked to Huntington's disease

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Familial predisposition to recurrent mutations causing Huntington's disease: genetic risk to sibs of sporadic cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Recent insights into the molecular pathogenesis of Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Reduced penetrance of the Huntington's disease mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Dynamic mutation in Dutch Huntington's disease patients: increased paternal repeat instability extending to within the normal size range

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Homozygotes for Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Rate of functional decline in Huntington's disease. Huntington Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Huntington's disease: confirmation of diagnosis and presymptomatic testing in Spanish families by genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Homozygosity for Machado-Joseph disease gene enhances phenotypic severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Guidelines for the molecular genetics predictive test in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Laboratory Guidelines for Huntington Disease Genetic Testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Unified Huntington's disease rating scale: Reliability and consistency

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

Analysis of the (CAG)n repeat causing Huntington's disease in a Mexican population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Spinocerebellar ataxia type 6. Molecular and clinical features of 35 Japanese patients including one homozygous for the CAG repeat expansion

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Mexican geneticists' views of ethical issues in genetics testing and screening. Are eugenic principles involved?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0004.2002.610607.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1399-0004.2002.610607.X

1 reference

11 December 2017

1 reference